There is evidence of an increase in serum SPX levels in severely obese patients following 6 months after the Roux-En-Y gastric bypass surgery and the associated weight loss (44), implying dysregulation of SPX in fat metabolism during obesity. The gene discussed is SPX; the disease is obesity due to melanocortin 4 receptor deficiency.